AR054381A1 - DRUG CONTROLLED METHOD OF DRUG THROUGH THE SKIN - Google Patents

DRUG CONTROLLED METHOD OF DRUG THROUGH THE SKIN

Info

Publication number
AR054381A1
AR054381A1 ARP060102384A ARP060102384A AR054381A1 AR 054381 A1 AR054381 A1 AR 054381A1 AR P060102384 A ARP060102384 A AR P060102384A AR P060102384 A ARP060102384 A AR P060102384A AR 054381 A1 AR054381 A1 AR 054381A1
Authority
AR
Argentina
Prior art keywords
drug
skin
solubilized
vitamin
film
Prior art date
Application number
ARP060102384A
Other languages
Spanish (es)
Inventor
Philippe Andres
Claire Mallard
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of AR054381A1 publication Critical patent/AR054381A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para la liberacion controlada de una droga a través de la piel, método que comprende administrar topicamente una composicion que comprende por lo menos una droga solubilizada, una silicona formadora de película y por lo menos un solvente volátil. Reivindicacion 4: El método de acuerdo con la reivindicacion 1, caracterizado porque la composicion comprende vitamina D solubilizada o un análogo de la vitamina D. Reivindicacion 7: El método de acuerdo con la reivindicacion 1, caracterizado porque la composicion comprende un corticosteroide solubilizado. Reivindicacion 11: El método de acuerdo con la reivindicacion 1, caracterizado porque el solvente volátil es seleccionado entre el grupo que consiste en alcanoles, alquilglicoles, alquilcetonas y/o alquil ésteres en donde las partes alquilo contienen de 1 a 6 átomos de carbono. Reivindicacion 13: El método de acuerdo con la reivindicacion 1, caracterizado porque la silicona formadora de película comprende por lo menos un elastomero de poliorganosiloxano.Method for the controlled release of a drug through the skin, a method comprising topically administering a composition comprising at least one solubilized drug, a film-forming silicone and at least one volatile solvent. Claim 4: The method according to claim 1, characterized in that the composition comprises solubilized vitamin D or an analogue of vitamin D. Claim 7: The method according to claim 1, characterized in that the composition comprises a solubilized corticosteroid. Claim 11: The method according to claim 1, characterized in that the volatile solvent is selected from the group consisting of alkanols, alkylglycols, alkyl ketones and / or alkyl esters wherein the alkyl parts contain from 1 to 6 carbon atoms. Claim 13: The method according to claim 1, characterized in that the film-forming silicone comprises at least one polyorganosiloxane elastomer.

ARP060102384A 2005-06-10 2006-06-08 DRUG CONTROLLED METHOD OF DRUG THROUGH THE SKIN AR054381A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68928205P 2005-06-10 2005-06-10

Publications (1)

Publication Number Publication Date
AR054381A1 true AR054381A1 (en) 2007-06-20

Family

ID=37137556

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102384A AR054381A1 (en) 2005-06-10 2006-06-08 DRUG CONTROLLED METHOD OF DRUG THROUGH THE SKIN

Country Status (11)

Country Link
EP (1) EP1901709A2 (en)
JP (1) JP2008542423A (en)
KR (1) KR20080016612A (en)
CN (1) CN101247787B (en)
AR (1) AR054381A1 (en)
AU (1) AU2006256860B2 (en)
BR (1) BRPI0613230A2 (en)
CA (1) CA2610755A1 (en)
MX (1) MX2007015672A (en)
RU (1) RU2008100037A (en)
WO (1) WO2006131401A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
BRPI0808660A2 (en) * 2007-03-08 2014-08-19 Crescendo Thetapeutics Llc CURATIVE FORMULATIONS TO PREVENT AND REDUCE SCAR TRAINING
JP2010533187A (en) 2007-07-11 2010-10-21 ダウ・コーニング・コーポレイション Composition for delivering a drug
BR112012001098A2 (en) * 2009-07-09 2015-09-01 Crescendo Therapeutics Llc Wound Healing Method and Scar Modulation
CA2785249A1 (en) * 2009-12-22 2011-06-30 Leo Pharma A/S Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same
TW201636025A (en) * 2015-04-15 2016-10-16 Maruho Kk Pharmaceutical composition for skin
KR20190026397A (en) 2017-09-05 2019-03-13 안준배 noise filtering device and method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JPH03275619A (en) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk External agent composition
JP3251717B2 (en) * 1992-06-29 2002-01-28 花王株式会社 External preparation for skin
JP3573803B2 (en) * 1994-02-16 2004-10-06 ポーラ化成工業株式会社 External preparation for skin
AU1876797A (en) * 1996-03-16 1997-10-10 Hoechst Aktiengesellschaft Topical formulations for the treatment of nail psoriasis
GB9902812D0 (en) * 1998-06-18 1999-03-31 Dow Corning Sa Composition for delivering pharmaceutically active agents
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
AU5146100A (en) * 1999-05-28 2000-12-18 Neutrogena Corporation Water-in-oil emulsion comprising a silicone gel containing vitamin
US6365670B1 (en) * 2000-03-10 2002-04-02 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics
DE10019128A1 (en) * 2000-04-18 2001-11-15 Wella Ag Aerosol foam for hair treatment
US6410038B1 (en) * 2000-06-14 2002-06-25 Dow Corning Corporation Water-in-oil-in-polar solvent emulsions
PL212660B1 (en) * 2000-10-27 2012-11-30 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
JP2004189639A (en) * 2002-12-09 2004-07-08 Pola Chem Ind Inc Emulsified composition
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
DE602004012440T2 (en) * 2003-11-21 2009-03-26 Galderma Research & Development SPIRITUAL COMPOSITION FOR THE ADMINISTRATION OF VITAMIN D DERIVATIVES
FR2871697B1 (en) * 2004-06-17 2007-06-29 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE OIL PHASE

Also Published As

Publication number Publication date
CN101247787B (en) 2011-10-05
AU2006256860B2 (en) 2012-04-19
MX2007015672A (en) 2008-02-20
CA2610755A1 (en) 2006-12-14
JP2008542423A (en) 2008-11-27
BRPI0613230A2 (en) 2011-01-04
EP1901709A2 (en) 2008-03-26
CN101247787A (en) 2008-08-20
KR20080016612A (en) 2008-02-21
AU2006256860A1 (en) 2006-12-14
RU2008100037A (en) 2009-07-20
WO2006131401A3 (en) 2007-03-15
WO2006131401A2 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
AR054381A1 (en) DRUG CONTROLLED METHOD OF DRUG THROUGH THE SKIN
CR9351A (en) COMPOSITIONS AND METHODS FOR TOPICA APPLICATION AND TRANSDERMIC SUPPLY OF BOTULIN TOXIN
NI201000193A (en) ORAL FORMULATIONS OF CITIDINE ANALOGUES AND METHODS OF USE OF THE SAME.
BR112015022223A2 (en) topical compositions and methods of treating topical disorders
AR050717A1 (en) PHARMACEUTICAL COMPOSITIONS
CO6311008A2 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
BRPI0516830A (en) conveniently implantable sustained release drug compositions
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
CU20060153A7 (en) NEW CRYSTAL FORM V AGOMELATINE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY30442A1 (en) PHARMACCUTIC COMPOSITIONS OF ROPINIROL, USE METHODS, PREPARATION PROCESS AND APPLICATIONS.
AR047799A1 (en) SOFT GELATIN CAPSULE CONTAINING A PHARMACEUTICAL FORMULATION WITH AT LEAST ONE OMEGA-3 POLY-INSATURATED FATTY ACID
BR112014010645A2 (en) perfuming compositions and uses thereof
CO2019005729A2 (en) Preparation of solid cyclodextrin complexes for the supply of ophthalmic active pharmaceutical ingredients
CL2011000144A1 (en) Compounds derived from benzo (1,4) dioxin-2-ylmethyl-sulfamide; pharmaceutical compositions containing them; process to prepare them and use in the treatment of anxiety, epilepsy, pain, substance abuse, related disorders, among others.
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
BRPI0519070A2 (en) lyophilized keratinocyte growth factor composition, methods for preparing a lyophilized keratinocyte growth factor, and for treating a disease, and kit for preparing an aqueous pharmaceutical composition
ATE492271T1 (en) METHOD FOR PRODUCING A DRUG EXTRACT CONTAINING HYDROXYSTILBENE
BR112015020049A8 (en) composition in the form of an oil-in-water emulsion and cosmetic processes
AR046642A1 (en) COMPOSITION IN THE FORM OF A SPRAY THAT INCLUDES A PHARMACEUTICAL ASSETS, AT LEAST A VOLATILE SILICONE AND A NON-VOLATILE OIL PHASE
AR077372A1 (en) COMPOSITIONS AND METHODS TO TREAT OTHAL OR NASAL OPHTHALM INFECTIONS
BR0209327A (en) Composition for treatment of drug-induced constipation
DE60202278D1 (en) ACTIVATION OF NATURAL KILLER CELLS BY ADENOSINE A3 RECEPTOR AGONISTS
BRPI0606373A2 (en) syrup composition comprising dexibuprofen as an active ingredient and method for preparing it
DOP2009000262A (en) A PROLONGED RELEASE COMPOSITION THAT INCLUDES A SOMATOSTATIN DERIVATIVE IN MICROPARTICLES

Legal Events

Date Code Title Description
FB Suspension of granting procedure